Irritable Bowel Syndrome Market Vendor Analysis & Forecast to 2023

Irritable Bowel Syndrome (IBS) Market Size, Share, Trends, Company

Profiles, Demand, Insights, Analysis, Research, Report, Opportunities,

Segmentation and Forecast To 2023

Summary

Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort

associated with altered bowel function. Although IBS is not a life-threatening disorder, it has a

considerable effect on patients' quality of life (QOL). In terms of volume, the IBS market is a

large, albeit naive, one, with only a small number of pharmacotherapies indicated for the

treatment of the disorder, and it is also characterized by significant unmet needs.

As of October 2014, there were four products indicated for IBS in the 7MM. These include the

constipation-predominant IBS (IBS-C) therapies, Sucampo/Takeda/Abbott's Amitiza

(lubiprostone) and Ironwood/Actavis/Almirall/Astellas' Linzess (linaclotide), and the diarrheapredominant IBS (IBS-D) therapies, Prometheus' Lotronex (alosetron) and Astellas' Irribow

(ramosetron). Antidepressants and antibiotics (mainly Salix/Alfa Wassermann/Norgine/BamaGeve's Xifaxan [rifaximin]), are also commonly used off-label to treat IBS. GlobalData

anticipates that four new therapies have the potential to enter the IBS market during the 20132023 forecast period. This includes Furiex's (Actavis') eluxadoline and Menarini's ibodutant for

IBS-D, and Synergy's plecanatide and AstraZeneca/Ardelyx's tenapanor for IBS-C. In addition,

Xifaxan is in development for IBS-D, and has the potential to gain a label expansion for this

indication during the forecast period.

Read Complete Report with TOC: http://www.radiantinsights.com/research/pharmapointirritable-bowel-syndrome-global-drug-forecast-and-market-analysis-to-2023

Highlights

Key Questions Answered

- What do physicians think about Ironwood/Actavis/Almirall/Astellas' Linzess and what will be

the impact in the IBS market following its launch in 2012 in the US and 2013 in the 5EU region?

- What will be the uptake of...